Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pathogenic role of anti-signal recognition protein and anti-3-Hydroxy-3-methylglutaryl-CoA reductase antibodies in necrotizing myopathies: Myofiber atrophy and impairment of muscle regeneration in necrotizing autoimmune myopathies.
Arouche-Delaperche L, Allenbach Y, Amelin D, Preusse C, Mouly V, Mauhin W, Tchoupou GD, Drouot L, Boyer O, Stenzel W, Butler-Browne G, Benveniste O. Arouche-Delaperche L, et al. Among authors: amelin d. Ann Neurol. 2017 Apr;81(4):538-548. doi: 10.1002/ana.24902. Ann Neurol. 2017. PMID: 28224701
Long-term exposure to Myozyme results in a decrease of anti-drug antibodies in late-onset Pompe disease patients.
Masat E, Laforêt P, De Antonio M, Corre G, Perniconi B, Taouagh N, Mariampillai K, Amelin D, Mauhin W, Hogrel JY, Caillaud C, Ronzitti G, Puzzo F, Kuranda K, Colella P, Mallone R, Benveniste O, Mingozzi F; French Pompe Registry Study Group. Masat E, et al. Among authors: amelin d. Sci Rep. 2016 Nov 4;6:36182. doi: 10.1038/srep36182. Sci Rep. 2016. PMID: 27812025 Free PMC article.
Necrosis in anti-SRP+ and anti-HMGCR+myopathies: Role of autoantibodies and complement.
Allenbach Y, Arouche-Delaperche L, Preusse C, Radbruch H, Butler-Browne G, Champtiaux N, Mariampillai K, Rigolet A, Hufnagl P, Zerbe N, Amelin D, Maisonobe T, Louis-Leonard S, Duyckaerts C, Eymard B, Goebel HH, Bergua C, Drouot L, Boyer O, Benveniste O, Stenzel W. Allenbach Y, et al. Among authors: amelin d. Neurology. 2018 Feb 6;90(6):e507-e517. doi: 10.1212/WNL.0000000000004923. Epub 2018 Jan 12. Neurology. 2018. PMID: 29330311
JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis.
Ladislau L, Suárez-Calvet X, Toquet S, Landon-Cardinal O, Amelin D, Depp M, Rodero MP, Hathazi D, Duffy D, Bondet V, Preusse C, Bienvenu B, Rozenberg F, Roos A, Benjamim CF, Gallardo E, Illa I, Mouly V, Stenzel W, Butler-Browne G, Benveniste O, Allenbach Y. Ladislau L, et al. Among authors: amelin d. Brain. 2018 Jun 1;141(6):1609-1621. doi: 10.1093/brain/awy105. Brain. 2018. PMID: 29741608
Deep characterization of the anti-drug antibodies developed in Fabry disease patients, a prospective analysis from the French multicenter cohort FFABRY.
Mauhin W, Lidove O, Amelin D, Lamari F, Caillaud C, Mingozzi F, Dzangué-Tchoupou G, Arouche-Delaperche L, Douillard C, Dussol B, Leguy-Seguin V, D'Halluin P, Noel E, Zenone T, Matignon M, Maillot F, Ly KH, Besson G, Willems M, Labombarda F, Masseau A, Lavigne C, Froissart R, Lacombe D, Ziza JM, Hachulla E, Benveniste O. Mauhin W, et al. Among authors: d halluin p, amelin d. Orphanet J Rare Dis. 2018 Jul 31;13(1):127. doi: 10.1186/s13023-018-0877-4. Orphanet J Rare Dis. 2018. PMID: 30064518 Free PMC article.
Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.
Mariampillai K, Granger B, Amelin D, Guiguet M, Hachulla E, Maurier F, Meyer A, Tohmé A, Charuel JL, Musset L, Allenbach Y, Benveniste O. Mariampillai K, et al. Among authors: amelin d. JAMA Neurol. 2018 Dec 1;75(12):1528-1537. doi: 10.1001/jamaneurol.2018.2598. JAMA Neurol. 2018. PMID: 30208379 Free PMC article.
CD8+T-bet+ cells as a predominant biomarker for inclusion body myositis.
Dzangué-Tchoupou G, Mariampillai K, Bolko L, Amelin D, Mauhin W, Corneau A, Blanc C, Allenbach Y, Benveniste O. Dzangué-Tchoupou G, et al. Among authors: amelin d. Autoimmun Rev. 2019 Apr;18(4):325-333. doi: 10.1016/j.autrev.2019.02.003. Epub 2019 Feb 28. Autoimmun Rev. 2019. PMID: 30825520 Review.
Cornea verticillata and acroparesthesia efficiently discriminate clusters of severity in Fabry disease.
Mauhin W, Benveniste O, Amelin D, Montagner C, Lamari F, Caillaud C, Douillard C, Dussol B, Leguy-Seguin V, D'Halluin P, Noel E, Zenone T, Matignon M, Maillot F, Ly KH, Besson G, Willems M, Labombarda F, Masseau A, Lavigne C, Lacombe D, Maillard H, Lidove O. Mauhin W, et al. Among authors: amelin d. PLoS One. 2020 May 22;15(5):e0233460. doi: 10.1371/journal.pone.0233460. eCollection 2020. PLoS One. 2020. PMID: 32442237 Free PMC article.
Cytokine profile as a prognostic tool in coronavirus disease 2019. Comment on "Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome" by Quartuccio et al. Joint Bone Spine. 2020;87:191-93.
Vieira M, Maalouf G, Hasan M, Le Joncour A, Karkeni E, Idir M, Amelin D, Salem JE, Gougis P, Lacorte JM, Biard L, Benveniste O, Cacoub P, Saadoun D, Allenbach Y; behalf of DIMICOVID. Vieira M, et al. Among authors: amelin d. Joint Bone Spine. 2021 Jan;88(1):105074. doi: 10.1016/j.jbspin.2020.09.006. Epub 2020 Sep 17. Joint Bone Spine. 2021. PMID: 32950702 Free PMC article. No abstract available.
Sphingosine-1-Phosphate Levels Are Higher in Male Patients with Non-Classic Fabry Disease.
Mauhin W, Tebani A, Amelin D, Abily-Donval L, Lamari F, London J, Douillard C, Dussol B, Leguy-Seguin V, Noel E, Masseau A, Lacombe D, Maillard H, Bekri S, Lidove O, Benveniste O. Mauhin W, et al. Among authors: amelin d. J Clin Med. 2022 Feb 24;11(5):1233. doi: 10.3390/jcm11051233. J Clin Med. 2022. PMID: 35268324 Free PMC article.
17 results